2013
DOI: 10.1371/journal.pone.0064991
|View full text |Cite
|
Sign up to set email alerts
|

The Relative Timing of Mutations in a Breast Cancer Genome

Abstract: Many tumors have highly rearranged genomes, but a major unknown is the relative importance and timing of genome rearrangements compared to sequence-level mutation. Chromosome instability might arise early, be a late event contributing little to cancer development, or happen as a single catastrophic event. Another unknown is which of the point mutations and rearrangements are selected. To address these questions we show, using the breast cancer cell line HCC1187 as a model, that we can reconstruct the likely hi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 44 publications
0
16
0
Order By: Relevance
“…The mutations or rearrangements of CAMTA1 have been reported in breast cancers. 22 Such genetic alterations may contribute to the aberrant expression of CAMTA1 in breast cancer, although our case was negative for CAMTA1 rearrangement by FISH.…”
Section: Discussionmentioning
confidence: 60%
“…The mutations or rearrangements of CAMTA1 have been reported in breast cancers. 22 Such genetic alterations may contribute to the aberrant expression of CAMTA1 in breast cancer, although our case was negative for CAMTA1 rearrangement by FISH.…”
Section: Discussionmentioning
confidence: 60%
“…Both the karyotype and single cell sequencing suggest that the cell line duplicated its entire karyotype after most of the rearrangements seen. The translocations-the 1;3, 1;10;18 and 7;15 translocations-fit the Dutrillaux monosomic pattern of karyotype evolution, in which two normal chromosomes are replaced by one unbalanced translocation, resulting in copy number loss and (if before genome duplication) LOH 6,11 .…”
Section: Validation From Spectral Karyotypingmentioning
confidence: 98%
“…Truth sets representing genomes of different ploidy levels were created by comparison with karyotype data (where available, i.e. Newman et al, 2013) and by manual inspection of coverage, allele ratios and read mappings. The simulation strategy controlled for (1) number of clones, (2) percentage of polyclonal non-root variants, (3) preponderance of the major clone and (4) sample purity (Supplementary Material, Table 1 and 2).…”
Section: Large-scale Simulation Of Tumour Plocyclonalitymentioning
confidence: 99%